Here are three stock picks by brokerage firms.
Tata Steel Credit Suisse maintains outperform with target price at Rs 500 per share. It has raised FY17/18 EU EBITDA/tonne rising to USD 50/ versus USD 44/tonne earlier.
Glenmark Credit Suisse maintains neutral rating due to high profit concentration in Mupirocin as upside risk exists from out-licensing opportunity from innovative R&D pipeline. Mupirocin cream accounts for 18 percent of FY18 EPS, as risk of competition is high.
IRB Infra CLSA maintains buy rating but the company is no longer a double-bagger. It has cut target price to Rs 330 per share from Rs 340 per share earlier. Next catalyst is InvIT listing that could release USD 650 million in equity per units.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!